19373111000001105: Linagliptin (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

65319901000001115 Linagliptin (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

65320001000001118 Linagliptin en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Linagliptin	Is a	Substance with dipeptidyl peptidase IV inhibitor mechanism of action	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Linagliptin 5mg tablets	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd)	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 5mg tablets 28 tablet	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Trajenta 5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 850mg tablets	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/850mg tablets (Boehringer Ingelheim Ltd)	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd)	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Linagliptin 2.5mg / Metformin 850mg tablets 56 tablet	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/850mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets	Has specific active ingredient	False	Linagliptin	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets